{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:01:49Z","timestamp":1794344509126,"version":"4.9.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.survophthal.2023.07.006","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T17:29:47Z","timestamp":1690565387000},"page":"1011-1026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"68","author":[{"given":"Xiu Juan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu Nian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang Yao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang Tian","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi Xuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement C.","family":"Tham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Pui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.survophthal.2023.07.006_bib1","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1167\/iovs.14-16006","article-title":"Subfoveal choroidal thickness changes following anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization","volume":"56","author":"Ahn","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"22","key":"10.1016\/j.survophthal.2023.07.006_bib2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.survophthal.2023.07.006_bib3","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1167\/iovs.11-9405","article-title":"Vascular endothelial growth factor gene polymorphisms and choroidal neovascularization in highly myopic eyes","volume":"53","author":"Akagi-Kurashige","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2023.07.006_bib4","first-page":"113","article-title":"Choroidal and retinal blood flow changes in degenerative myopia","volume":"31","author":"Akyol","year":"1996","journal-title":"Can J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2023.07.006_bib5","first-page":"880","article-title":"Estimation of prevalence and incidence rates and causes of blindness in Israel, 1998-2003","volume":"8","author":"Avisar","year":"2006","journal-title":"Isr Med Assoc J"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/IAE.0000000000000015","article-title":"Macular choroidal volume variations in highly myopic eyes with myopic traction maculopathy and choroidal neovascularization","volume":"34","author":"Barteselli","year":"2014","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.survophthal.2023.07.006_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.exer.2003.10.013","article-title":"Pigment epithelium-derived factor in the monkey retinal pigment epithelium and interphotoreceptor matrix: apical secretion and distribution","volume":"78","author":"Becerra","year":"2004","journal-title":"Exp Eye Res"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236071","article-title":"Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients","volume":"15","author":"Bilbao-Malav\u00e9","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.survophthal.2023.07.006_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/IAE.0b013e31818358b2","article-title":"Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia","volume":"28","author":"Chan","year":"2008","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.07.006_bib10","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.12.04026","article-title":"A systematic review of clinical practice guidelines for myopic macular degeneration","volume":"12","author":"Chen","year":"2022","journal-title":"J Glob Health"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib11","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1111\/aos.12117","article-title":"Choroidal thickness and risk characteristics of eyes with myopic choroidal neovascularization","volume":"91","author":"Cheung","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2023.07.006_bib12","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.ophtha.2017.04.028","article-title":"Myopic choroidal neovascularization: review, guidance, and consensus statement on management","volume":"124","author":"Cheung","year":"2017","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.survophthal.2023.07.006_bib13","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1038\/s41433-021-01479-0","article-title":"Watersheds and mini-watersheds","volume":"35","author":"Cheung","year":"2021","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/bjophthalmol-2014-306465","article-title":"Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation","volume":"99","author":"Costagliola","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-023-02451-w","article-title":"Correlation between AI-measured lacquer cracks extension and development of myopic choroidal neovascularization","author":"Crincoli","year":"2023","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/bjo.86.7.771","article-title":"Retrobulbar circulation in myopic patients with or without myopic choroidal neovascularisation","volume":"86","author":"Dimitrova","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib17","article-title":"Hospital-based study of risk factors associated with development of myopic macular neovascularization in highly myopic eyes","author":"Du","year":"2022","journal-title":"Ophthalmic Research"},{"issue":"2","key":"10.1016\/j.survophthal.2023.07.006_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"7109","key":"10.1016\/j.survophthal.2023.07.006_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"6 Suppl","key":"10.1016\/j.survophthal.2023.07.006_bib20","first-page":"S38","article-title":"Choroidal thickness measurement in highly myopic eyes using SD-OCT","volume":"43","author":"El Matri","year":"2012","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"8","key":"10.1016\/j.survophthal.2023.07.006_bib21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jfo.2013.03.009","article-title":"Macular choroidal thickness assessment with SD-OCT in high myopia with or without choroidal neovascularization","volume":"36","author":"El Matri","year":"2013","journal-title":"J Fr Ophtalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2023.07.006_bib22","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.ophtha.2008.03.004","article-title":"Myopic choroidal neovascularization genetics","volume":"115","author":"Fernandez-Robredo","year":"2008","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib23","doi-asserted-by":"crossref","first-page":"e288","DOI":"10.1111\/aos.14893","article-title":"Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the fight retinal blindness! Registry","volume":"100","author":"Gabrielle","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2023.07.006_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ajo.2014.06.004","article-title":"Delayed patchy choroidal filling in the comparison of age-related macular degeneration treatments trials (CATT)","volume":"158","author":"Gewaily","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2023.07.006_bib25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bjo.67.4.209","article-title":"Common causes of blindness and visual handicap in the west of Scotland","volume":"67","author":"Ghafour","year":"1983","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2023.07.006_bib26","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.5301\/ejo.5000875","article-title":"Choroidal neovascularization and coincident perforating scleral vessels in pathologic myopia","volume":"27","author":"Giuffr\u00e8","year":"2017","journal-title":"Eur J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2023.07.006_bib27","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.ophtha.2009.11.003","article-title":"Long-term pattern of progression of myopic maculopathy: a natural history study","volume":"117","author":"Hayashi","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.07.006_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-023-02423-0","article-title":"Using a combination of peripapillary atrophy area and choroidal thickness for the prediction of different types of myopic maculopathy","author":"He","year":"2023","journal-title":"Eye (Lond)"},{"issue":"11","key":"10.1016\/j.survophthal.2023.07.006_bib29","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.survophthal.2023.07.006_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0002-9394(81)90170-7","article-title":"Pathologic myopia and choroidal neovascularization","volume":"91","author":"Hotchkiss","year":"1981","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.exer.2018.06.010","article-title":"MicroRNA-188-5p regulates contribution of bone marrow-derived cells to choroidal neovascularization development by targeting MMP-2\/13","volume":"175","author":"Hou","year":"2018","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.07.006_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ophtha.2003.05.011","article-title":"Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai eye study","volume":"111","author":"Hsu","year":"2004","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib33","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1167\/iovs.09-3493","article-title":"Ocular risk factors for choroidal neovascularization in pathologic myopia","volume":"51","author":"Ikuno","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2023.07.006_bib34","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/IAE.0b013e318174417a","article-title":"Lacquer crack formation and choroidal neovascularization in pathologic myopia","volume":"28","author":"Ikuno","year":"2008","journal-title":"Retina"},{"issue":"8","key":"10.1016\/j.survophthal.2023.07.006_bib35","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1167\/iovs.08-3325","article-title":"Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography","volume":"50","author":"Ikuno","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2023.07.006_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bjophthalmol-2018-312015","article-title":"Possible connection of short posterior ciliary arteries to choroidal neovascularisations in eyes with pathologic myopia","volume":"103","author":"Ishida","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib37","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.ophtha.2006.04.022","article-title":"Prevalence and causes of low vision and blindness in a Japanese adult population: the Tajimi study","volume":"113","author":"Iwase","year":"2006","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.survophthal.2023.07.006_bib38","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1007\/s10792-022-02261-1","article-title":"The efficacy of different anti-vascular endothelial growth factor agents and prognostic biomarkers in monitoring of the treatment for myopic choroidal neovascularization","volume":"42","author":"Karasu","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/eye.2011.94","article-title":"The analysis of lacquer crack in the assessment of myopic choroidal neovascularization","volume":"25","author":"Kim","year":"2011","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.survophthal.2023.07.006_bib40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1089\/jop.2019.0080","article-title":"Comparison of efficacy of intravitreal ranibizumab and aflibercept in eyes with myopic choroidal neovascularization: 24-month follow-up","volume":"36","author":"Korol","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.survophthal.2023.07.006_bib41","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000027415","article-title":"Blindness incidence in Germany: a population-based study from W\u00fcrttemberg-Hohenzollern","volume":"213","author":"Krumpaszky","year":"1999","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1016\/j.survophthal.2023.07.006_bib42","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s10792-022-02423-1","article-title":"The correlation of atrophy, traction and neovascularization in myopic choroidal neovascularization according to a novel myopic maculopathy classification system (atrophy (A), traction (T), neovascularization (N): ATN)","volume":"42","author":"Kurt","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib43","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.ajo.2012.11.021","article-title":"Angiographic and optical coherence tomography characteristics of recent myopic choroidal neovascularization","volume":"155","author":"Leveziel","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2023.07.006_bib44","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1167\/iovs.12-9538","article-title":"Genetic factors for choroidal neovascularization associated with high myopia","volume":"53","author":"Leveziel","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.07.006_bib45","article-title":"Comparison of intraocular cytokine levels of choroidal neovascularization secondary to different retinopathies","volume":"8","author":"Liu","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib46","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000522511","article-title":"MiRNA-21- HIF-1alpha-VEGF axis is associated with myopic choroidal neovascularization in guinea pigs","volume":"65","author":"Liu","year":"2022","journal-title":"Ophthalmic Res"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib47","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/OPX.0b013e31828daa6e","article-title":"C-reactive protein and complement components in patients with pathological myopia","volume":"90","author":"Long","year":"2013","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.survophthal.2023.07.006_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/1504834","article-title":"Choroidal vascular density quantification in high myopia with or without choroidal neovascularization using optical coherence tomography angiography","volume":"2023","author":"Lu","year":"2023","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib49","first-page":"7","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil Med Res"},{"issue":"6","key":"10.1016\/j.survophthal.2023.07.006_bib50","first-page":"264","article-title":"Causes of blindness in Canada: an analysis of 24605 cases registered with the Canadian National Institute for the Blind","volume":"92","author":"Macdonald","year":"1965","journal-title":"Can Med Assoc J"},{"issue":"10","key":"10.1016\/j.survophthal.2023.07.006_bib51","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/ph14101042","article-title":"Ten-year outcomes of intravitreal bevacizumab for myopic choroidal neovascularization: analysis of prognostic factors","volume":"14","author":"Mallone","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ophtha.2013.06.043","article-title":"Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia","volume":"121","author":"Miyake","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2023.07.006_bib53","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1167\/iovs.13-12280","article-title":"Evaluation of pigment epithelium-derived factor and complement factor I polymorphisms as a cause of choroidal neovascularization in highly myopic eyes","volume":"54","author":"Miyake","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2023.07.006_bib54","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/eye.2009.215","article-title":"ARMS2\/HTRA1 and CFH polymorphisms are not associated with choroidal neovascularization in highly myopic eyes of the elderly Japanese population","volume":"24","author":"Nakanishi","year":"2010","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.preteyeres.2012.04.001","article-title":"Choroidal neovascularization in pathological myopia","volume":"31","author":"Neelam","year":"2012","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14740338.2021.1952979","article-title":"Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization","volume":"21","author":"Ng","year":"2022","journal-title":"Expert Opin Drug Saf"},{"issue":"12","key":"10.1016\/j.survophthal.2023.07.006_bib57","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/14712598.2021.1830969","article-title":"Ranibizumab for myopic choroidal neovascularization","volume":"20","author":"Ng","year":"2020","journal-title":"Expert Opin Biol Ther"},{"issue":"2","key":"10.1016\/j.survophthal.2023.07.006_bib58","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0002-9440(10)64891-2","article-title":"Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment","volume":"160","author":"Ohno-Matsui","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.preteyeres.2017.10.005","article-title":"Diagnosis and treatment guideline for myopic choroidal neovascularization due to pathologic myopia","volume":"63","author":"Ohno-Matsui","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.survophthal.2023.07.006_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.preteyeres.2018.12.001","article-title":"Posterior staphyloma in pathologic myopia","volume":"70","author":"Ohno-Matsui","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib61","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ajo.2015.01.022","article-title":"International photographic classification and grading system for myopic maculopathy","volume":"159","author":"Ohno-Matsui","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.12.001","article-title":"Updates of pathologic myopia","volume":"52","author":"Ohno-Matsui","year":"2016","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/iovs.62.5.5","article-title":"IMI pathologic myopia","volume":"62","author":"Ohno-Matsui","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2023.07.006_bib64","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.icu.0000120709.35941.e9","article-title":"Myopic choroidal neovascularization: natural course and treatment","volume":"15","author":"Ohno-Matsui","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib65","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/bjo.87.5.570","article-title":"Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia","volume":"87","author":"Ohno-Matsui","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib66","doi-asserted-by":"crossref","unstructured":"Page M.J., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 372:n71.","DOI":"10.1136\/bmj.n71"},{"issue":"4","key":"10.1016\/j.survophthal.2023.07.006_bib67","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ajo.2015.07.017","article-title":"Lacquer cracks and perforating scleral vessels in pathologic myopia: a possible causal relationship","volume":"160","author":"Querques","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2023.07.006_bib68","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/IAE.0000000000003675","article-title":"Long-term treatment outcomes after bevacizumab therapy for macular neovascularization in white patients with high myopia","volume":"43","author":"Ravenstijn","year":"2023","journal-title":"Retina"},{"issue":"12","key":"10.1016\/j.survophthal.2023.07.006_bib69","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1007\/s00417-020-04778-6","article-title":"Clinical features of simple hemorrhage and myopic choroidal neovascularization associated with lacquer cracks in pathologic myopia","volume":"258","author":"Ren","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2023.07.006_bib70","first-page":"16242","article-title":"Variation in subfoveal choroidal thickness in patients with high myopia complicated by choroidal neovascularization","volume":"9","author":"Rong","year":"2016","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9394(99)80237-2","article-title":"Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration","volume":"125","author":"Ross","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib72","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/IAE.0000000000003290","article-title":"Relationship between myopic choroidal neovascularization activity and perforating scleral vessels in high myopia","volume":"42","author":"Ruiz-Medrano","year":"2022","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.07.006_bib73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.preteyeres.2018.10.005","article-title":"Myopic maculopathy: current status and proposal for a new classification and grading system (ATN)","volume":"69","author":"Ruiz-Medrano","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib74","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1755-3768.2009.01717.x","article-title":"Vascular endothelial growth factor in the aqueous humour in eyes with myopic choroidal neovascularization","volume":"89","author":"Sawada","year":"2011","journal-title":"Acta Ophthalmol"},{"issue":"13","key":"10.1016\/j.survophthal.2023.07.006_bib75","first-page":"3287","article-title":"Induction of vascular endothelial growth factor after application of mechanical stress to retinal pigment epithelium of the rat in vitro","volume":"40","author":"Seko","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2023.07.006_bib76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000455271","article-title":"Intraocular cytokines and their correlations with clinical parameters in patients with myopic choroidal neovascularization","volume":"237","author":"Shchuko","year":"2017","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2023.07.006_bib77","first-page":"2265","article-title":"Aqueous humor concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in high myopic patients","volume":"18","author":"Shin","year":"2012","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.survophthal.2023.07.006_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000339893","article-title":"Myopic maculopathy: a review","volume":"228","author":"Silva","year":"2012","journal-title":"Ophthalmologica"},{"issue":"9","key":"10.1016\/j.survophthal.2023.07.006_bib79","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/s41433-021-01427-y","article-title":"Choroidal arterial watershed zone topography and its relationship with maculopathy in highly myopic eyes","volume":"35","author":"Sun","year":"2021","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.survophthal.2023.07.006_bib80","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ajo.2005.10.012","article-title":"Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization","volume":"141","author":"Tong","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2023.07.006_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162296","article-title":"Evaluation of 10 AMD associated polymorphisms as a cause of choroidal neovascularization in highly myopic eyes","volume":"11","author":"Velazquez-Villoria","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib82","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/bjo.2009.163535","article-title":"Choroidal filling delay in choroidal neovascularisation due to pathological myopia","volume":"94","author":"Wakabayashi","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/257381","article-title":"Aqueous concentrations of vascular endothelial growth factor in eyes with high myopia with and without choroidal neovascularization","volume":"2013","author":"Wakabayashi","year":"2013","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053660","article-title":"Choroidal thickness and biometric markers for the screening of lacquer cracks in patients with high myopia","volume":"8","author":"Wang","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.survophthal.2023.07.006_bib85","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12886-015-0059-2","article-title":"Choroidal thickness and high myopia: a cross-sectional study and meta-analysis","volume":"15","author":"Wang","year":"2015","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib86","article-title":"Choroidal morphologic and vascular features in patients with myopic choroidal neovascularization and different levels of myopia based on image binarization of optical coherence tomography","volume":"8","author":"Wang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.survophthal.2023.07.006_bib87","unstructured":"G. Wells O. SB D. Connell et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Published 2000. Available at: http:\/\/refhub.elsevier.com\/S0376-8716(17)30284-3\/sbref0350."},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajo.2013.08.010","article-title":"Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review","volume":"157","author":"Wong","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2023.07.006_bib89","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/bjophthalmol-2014-305131","article-title":"Myopic choroidal neovascularisation: current concepts and update on clinical management","volume":"99","author":"Wong","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib90","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2415-11-10","article-title":"Causes and 3-year-incidence of blindness in Jing-An district, Shanghai, China 2001-2009","volume":"11","author":"Wu","year":"2011","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.07.006_bib91","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/8592729","article-title":"Study on factors associated with high myopia CNV in aqueous humor and serum","volume":"2022","author":"Xia","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.survophthal.2023.07.006_bib92","article-title":"Morphologic features of myopic choroidal neovascularization in pathologic myopia on swept-source optical coherence tomography","volume":"7","author":"Xie","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.survophthal.2023.07.006_bib93","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002970","article-title":"Role of dilated subfoveal choroidal veins in eyes with myopic macular neovascularization","volume":"41","author":"Xie","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.survophthal.2023.07.006_bib94","doi-asserted-by":"crossref","first-page":"1134.e1","DOI":"10.1016\/j.ophtha.2006.01.035","article-title":"Causes of blindness and visual impairment in urban and rural areas in Beijing: the Beijing eye study","volume":"113","author":"Xu","year":"2006","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2023.07.006_bib95","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/IAE.0000000000000311","article-title":"Associations of inflammatory cytokines with choroidal neovascularization in highly myopic eyes","volume":"35","author":"Yamamoto","year":"2015","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib96","doi-asserted-by":"crossref","first-page":"10584","DOI":"10.18632\/aging.202822","article-title":"Suppression of choroidal neovascularization by silencing of long non-coding RNA IPW","volume":"13","author":"Yang","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.survophthal.2023.07.006_bib97","article-title":"Perforating scleral vessels adjacent to myopic choroidal neovascularization achieved a poor outcome after intravitreal anti-VEGF therapy","volume":"9","author":"Yao","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib98","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","article-title":"Myopic choroidal neovascularization: a 10-year follow-up","volume":"110","author":"Yoshida","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.07.006_bib99","article-title":"Association between perforating scleral vessel and myopic maculopathy: a cross-sectional study of a Chinese cohort","volume":"8","author":"Yu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.survophthal.2023.07.006_bib100","article-title":"Difference in aqueous concentration and vitreous mass of cytokines in high myopias with and without choroidal neovascularization","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.survophthal.2023.07.006_bib101","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.7150\/thno.39488","article-title":"Circular RNA-ZBTB44 regulates the development of choroidal neovascularization","volume":"10","author":"Zhou","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.survophthal.2023.07.006_bib102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/02713683.2019.1648833","article-title":"Profiling and bioinformatic analysis of differentially expressed cytokines in aqueous humor of high myopic eyes - clues for anti-VEGF injections","volume":"45","author":"Zhu","year":"2020","journal-title":"Curr Eye Res"},{"issue":"12","key":"10.1016\/j.survophthal.2023.07.006_bib103","article-title":"Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia","volume":"12","author":"Zhu","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:55:29Z","timestamp":1758542129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625723001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0039625723001017"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.07.006","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of myopic choroidal neovascularization: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}